Graziella Portelli

The Design and Optimization

of Novel Human Dihydrofolate Reductase Inhibitors for the Management of Proliferative Disease

• Broschiertes Buch

Produktbeschreibung

Tetrahydrofolate, a derivative of Vitamin B9, acts a one-carbon donor during reactions necessary for the synthesis of essential nucleotide precursors. One of the enzymes which makes use of such metabolites, is Thymidylate synthesase, which is the only enzyme utilising one-carbon-transfers that in the end fails to produce tetrahydrofolate. It instead produces Dihydrofolate the reduced and insufficient form of folate. The Dihydrofolate reductase enzyme (DHFR) is the enzyme that recycles the dihydrofolate to tetrahydrofolate via a redox reaction. DHFR has a crucial role in cellular proliferation, as inhibition of this ubiquitous enzyme leads to cessation of cellular growth. This makes the DHFR enzyme an ideal target in humans for inhibiting proliferation in rapidly dividing cells, with clinical sequelae in conditions such as rheumatic disease, Crohn's disease, and malignant disease.

Produktdetails

• Verlag: LAP Lambert Academic Publishing
• Seitenzahl: 352
• Erscheinungstermin: 6. März 2018
• Englisch
• Abmessung: 220mm x 150mm x 22mm
• Gewicht: 542g
• ISBN-13: 9786138238560
• ISBN-10: 6138238567
• Artikelnr.: 52471023

Autorenporträt

After achieving her Masters in Pharmacy in 2015, Graziella started reading for her Post-Grad Doctorate in Pharmacy, at the University of Malta (in collaboration with UIC). She started her career in hospital pharmacy in 2016 and is currently the Departmental Pharmacist in charge of the Emergency Department at Mater Dei Hospital, Malta.